The Support in Opioid Introduction Period for Outpatients with Cancer by Palliative Care Staffs

Yoshihiro Yamamoto; Hiroaki Watanabe; Ayako Kondo; Yuko Deguchi; Shigeki Hirano; Aina Sakurai; Shoko Kumon; Rumiko Muraji; Megumi Motiyama; Yoshimi Okumura; Yasuyuki Asai; Takuya Odagiri

Return

The Support in Opioid Introduction Period for Outpatients with Cancer by Palliative Care Staffs

VernacularTitle:外来通院中のがん患者に対する緩和ケアチームスタッフによるオピオイド導入支援
Author: Yoshihiro YAMAMOTO ¹ ; Hiroaki WATANABE ² ; Ayako KONDO ³ ; Yuko DEGUCHI ¹ ; Shigeki HIRANO ¹ ; Aina SAKURAI ¹ ; Shoko KUMON ¹ ; Rumiko MURAJI ⁴ ; Megumi MOTIYAMA ⁴ ; Yoshimi OKUMURA ³ ; Yasuyuki ASAI ⁴ ; Takuya ODAGIRI ⁴
Author Information

1. Departments of Pharmacy, Komaki City Hospital
2. Departments of Palliative care, Komaki City Hospital
3. Home Palliative Care Asunaro Clinic
4. Departments of Nursing, Komaki City Hospital
Keywords: outpatients treated anticancer; pain control; opioid analgesics; patient education; telephone follow up
From:Palliative Care Research 2020;15(4):303-308
CountryJapan
Language:Japanese
Abstract: Introduction: Our palliative care staff began the support activity in opioid introduction for outpatients with cancer at Komaki City Hospital in March 2018, because it was difficult to make them understand about proper use of opioid analgesics and misinterpretation about abuse at the time of opioid introduction in outpatient settings. This study aimed to evaluate the effects of the activity (patient education on pain control, telephone follow up, and assessment of the symptom). Method: Outpatients with cancer receiving strong opioids for pain relief from January 2017 to March 2019 were eligible. We retrospectively investigated the difference of the variables between baseline and after the activity as follows; the ratios of prescribing immediate-release opioids, antiemetics, and laxatives when opioids were prescribed and side effects due to opioid analgesics appeared. Results: The study included 122 patients. The prescribing ratios of immediate-release opioids antiemetics and laxatives all increased from 90.7 to 98.5%, from 63.0 to 70.6%, and from 61.1 to 70.6%, respectively. The side effect incidence due to opioids with STAS-J 2 or more decreased from 12 (22.2%) to 9 (13.2%). Discussion: The activity could contribute to the provision of drug treatments and counselling needed for opioid therapy.